Detection of Epidemic Scarlet Fever Group A Streptococcus in Australia
Author(s) -
Mark J. Walker,
Stephan Brouwer,
Brian M. Forde,
Kate A. Worthing,
Liam McIntyre,
Lana Sundac,
Sam Maloney,
Leah W. Roberts,
Timothy C. Barnett,
Johanna Richter,
Amanda J. Cork,
Adam Irwin,
Yuanhai You,
Jianzhong Zhang,
Gordon Dougan,
KwokYung Yuen,
Victor Nizet,
Scott A. Beatson,
Keith Grimwood,
Mark R. Davies
Publication year - 2019
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz099
Subject(s) - scarlet fever , outbreak , medicine , pandemic , streptococcus pyogenes , virology , streptococcus , phylogenetic tree , microbiology and biotechnology , covid-19 , biology , infectious disease (medical specialty) , pathology , disease , bacteria , genetics , gene , staphylococcus aureus
Sentinel hospital surveillance was instituted in Australia to detect the presence of pandemic group A Streptococcus strains causing scarlet fever. Genomic and phylogenetic analyses indicated the presence of an Australian GAS emm12 scarlet fever isolate related to United Kingdom outbreak strains. National surveillance to monitor this pandemic is recommended.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom